Hagan Joseph P 4
4 · Regulus Therapeutics Inc. · Filed Jan 10, 2025
Insider Transaction Report
Form 4
Hagan Joseph P
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-01-09$1.30/sh+62,000$80,600→ 337,862 total - Award
Common Stock
2025-01-09$1.36/sh+218,750$297,500→ 275,862 total
Footnotes (2)
- [F1]On August 10, 2023, the reporting person was granted Restricted Stock Units (RSUs). The RSUs only vest upon achievement of a specified performance-based milestone. The performance criteria were met resulting in immediate vesting of 50% of the shares subject to the grant. The remaining 50% vest on the one year anniversary of the vesting commencement date, subject to the reporting person's Continuous Service to Regulus.
- [F2]On January 12, 2024, the reporting person was granted Restricted Stock Units (RSUs). The RSUs only vest upon achievement of a specified performance-based milestone. The performance criteria were met resulting in immediate vesting of 50% of the shares subject to the grant. The remaining 50% vest on the one year anniversary of the vesting commencement date, subject to the reporting person's Continuous Service to Regulus.